02-31994. Advisory Committees; Tentative Schedule of Meetings for 2003  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2003. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Theresa Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​oc/​advisory/​default.htm. The FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

    The following list announces FDA's tentatively scheduled advisory committee meetings for 2003. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area):

    Start Printed Page 77794
    Committee NameDates of MeetingsAdvisory Committee 5-Digit Information Line Code
    OFFICE OF THE COMMISSIONER
    Science Board to the Food and Drug AdministrationApril 9, November 612603
    CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
    Allergenic Products Advisory CommitteeApril 8, November 1812388
    Biological Response Modifiers Advisory CommitteeFebruary 27-28, June 9-10, October 9-1012389
    Blood Products Advisory CommitteeMarch 13-14, June 19-20, September 18-19, December 11-1219516
    Transmissible Spongiform Encephalopathies Advisory CommitteeFebruary 20-21, July 17-18, October 30-3112932
    Vaccines and Related Biological Products Advisory CommitteeFebruary 20-21, May 8-9, September 22-23, November 19-2012391
    CENTER FOR DRUG EVALUATION AND RESEARCH
    Advisory Committee for Pharmaceutical ScienceFebruary 12-13, March 12-13, September 17, October 21-2312539
    Advisory Committee for Reproductive Health DrugsMarch 24-25, August 18-19, November 13-1412537
    Anesthetic and Life Support Drugs Advisory CommitteeJune 26-27, December 11-1212529
    Anti-Infective Drugs Advisory CommitteeJanuary 8-9, March 4-5, June 10-11, October 15-1612530
    Antiviral Drugs Advisory CommitteeApril 29-30, September 1912531
    Arthritis Advisory CommitteeJanuary 30-31, September 512532
    Cardiovascular and Renal Drugs Advisory CommitteeJanuary 6-7, May 29-30, September 15-16, December 11-1212533
    Dermatologic and Ophthalmic Drugs Advisory CommitteeMarch 6-7, April 15-16, July 17-18, September 10-1112534
    Drug Safety and Risk Management Advisory CommitteeApril 24-25, September 18-1912535
    Endocrinologic and Metabolic Drugs Advisory CommitteeJanuary 13-15, June 12-13, September 11-1212536
    Gastrointestinal Drugs Advisory CommitteeJuly 1712538
    Nonprescription Drugs Advisory CommitteeMarch 6-7, June 13-14, September 16-1712541
    Start Printed Page 77795
    Oncologic Drugs Advisory CommitteeMarch 3-4, March 12-13, June 10-1112542
    Peripheral and Central Nervous System Drugs Advisory CommitteeJuly 1812543
    Psychopharmacologic Drugs Advisory CommitteeFebruary 27-28, September 4-512544
    Pulmonary-Allergy Drugs Advisory CommitteeMay 15-16, November 6-712545
    CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
    Food Advisory CommitteeFebruary 24-26, August 18-2010564
    Biotechnology Sub-CommitteeMarch 24-25, October 15-1610564
    Dietary Supplements Sub-CommitteeMarch 27-28, September 22-2310564
    Contaminants and Natural Toxicants Sub-CommitteeMarch 6-7, September 4-510564
    Nutrition Sub-CommitteeApril 28-29, November 3-410564
    Food Additives Sub-CommitteeJune 19-2010564
    CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
    Device Good Manufacturing Practice Advisory CommitteeNo meetings planned12398
    Medical Devices Advisory Committee:
    Anesthesiology and Respiratory Therapy Devices PanelMarch 27-28, May 7-8, September 4-5, November 10-1112624
    Circulatory System Devices PanelFebruary 21-22, April 24-25, June 26-27, August 28-29, October 23-24, December 11-1212625
    Clinical Chemistry and Clinical Toxicology Devices PanelFebruary 10-11, May 19, September 8-9, December 11-1212514
    Dental Products PanelFebruary 13-14, May 22-23, August 7-8, October 9-1012518
    Ear, Nose, and Throat Devices PanelApril 8-9, June 2-3, August 4-5, October 9-10, December 4-512522
    Gastroenterology and Urology Devices PanelJanuary 17, April 4, July 25, October 1712523
    General and Plastic Surgery Devices PanelFebruary 27-28, April 10-11, July 23-24, October 23-2412519
    General Hospital and Personal Use Devices PanelFebruary 27-28, May 15-16, August 18-19, November 20-2112520
    Start Printed Page 77796
    Hematology and Pathology Devices PanelMarch 14, June 20, October 312515
    Immunology Devices PanelMarch 17-18, June 9-10, September 15-1612516
    Medical Devices Dispute Resolution PanelNo meetings planned10232
    Microbiology Devices PanelMarch 27-28, May 5-6, August 7-8, October 16-1712517
    Molecular and Clinical Genetics PanelApril 24-25, July 17-18, November 13-1410231
    Neurological Devices PanelMarch 6-7, June 23-24, September 18-19, December 8-912513
    Obstetrics and Gynecology Devices PanelMarch 3-4, June 9-10, September 8-9, November 3-412524
    Ophthalmic Devices PanelMarch 13-14, May 22-23, July 10-11, September 11-12, November 6-712396
    Orthopaedic and Rehabilitation Devices PanelFebruary 20-21, May 29-30, August 27-28, November 20-2112521
    Radiological Devices PanelFebruary 4, May 20, August 12, November 1812526
    National Mammography Quality Assurance Advisory CommitteeApril 7-8, September 8-912397
    Technical Electronic Product Radiation Safety Standards CommitteeJune 1812399
    CENTER FOR VETERINARY MEDICINE
    Veterinary Medicine Advisory CommitteeMay 15, September 1512548
    NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
    Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and ContaminantsFebruary 10-13, June 23-2512560
    Science Advisory Board to the National Center for Toxicological ResearchJune 3-512559
    Start Signature

    Dated: December 12, 2002.

    William K. Hubbard,

    Associate Commissioner for Policy and Planning.

    End Signature End Supplemental Information

    [FR Doc. 02-31994 Filed 12-18-02; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
12/19/2002
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
02-31994
Pages:
77793-77796 (4 pages)
PDF File:
02-31994.pdf